Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Thursday, January 7, 2010, 6:15AM ET - U.S. Markets open in 3 hours and 15 minutes. Dow Up 0.02% Nasdaq  0.00%
NuVasive, Inc. (NUVA)On Jan 6: 32.06   0.00 (0.00%)  
MORE ON NUVA
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials

ProfileGet Profile for:
NuVasive, Inc.
7475 Lusk Boulevard
San Diego, CA 92121
United States - Map
Phone: 858-909-1800
Fax: 858-909-2000
Web Site: http://www.nuvasive.com

DETAILS 
Index Membership:N/A
Sector:Healthcare
Industry:Medical Instruments & Supplies
Full Time Employees:444

BUSINESS SUMMARY 
NuVasive, Inc., a medical device company, engages in the design, development, and marketing of products for the surgical treatment of spine disorders. Its products are used in applications for spine fusion surgery. The company’s products include a minimally disruptive surgical platform called Maximum Access Surgery (MAS), as well as cervical, biologics, and motion preservation products. Its MAS platform combines four categories of product offerings, including NeuroVision, a proprietary software-driven nerve avoidance system; MaXcess, a split-blade design retraction system providing enhanced surgical access to the spine; Biologics, which includes FormaGraft and Osteocel line of products; and specialized implants, such as SpheRx pedicle screw system, and CoRoent suite of implants, a titanium surgical mesh system with a line of precision-machined cervical and lumbar allograft implants, and related instrumentation. NuVasive also offers a range of bone allograft in patented saline packaging and spine implants, such as rods, plates, and screws, as well as Osteocel, a bone matrix product that offers three properties related to autograft, including osteoconduction, osteoinduction, and osteogenesis. The company’s motion preservation products include lateral total disc replacement (TDR). It sells its products through independent sales agencies and direct sales representatives primarily in the United States. The company was founded in 1997 and is headquartered in San Diego, California.
Key Statistics

COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on NuVasive, Inc.


    CORPORATE GOVERNANCE 
    NuVasive, Inc.'s Corporate Governance Quotient (CGQ®) as of 3-Jan-10 is better than 60.5% of Russell 3000 companies and 63.1% of Health Care Equipment & Services companies.
    Brought to you by Institutional Shareholder Services.

    KEY EXECUTIVES 
     PayExercised
    Mr. Alexis V. Lukianov , 54
    Chairman and Chief Exec. Officer
    $ 1.35M $ 8.21M
    Mr. Keith C. Valentine , 42
    Pres and Chief Operating Officer
    $ 900.00K $ 3.12M
    Mr. Patrick Miles , 44
    Pres of Americas
    $ 725.00K $ 1.54M
    Mr. Kevin C. O'Boyle , 54
    Principal Accounting Officer and Exec. VP
    $ 515.00K $ 4.04M
    Mr. Jeffrey P. Rydin , 43
    Exec. VP of Sales - Americas and Chairman of Global Sales Exec. Committee
    $ 750.00K $ 789.00K
    Dollar amounts are as of 31-Dec-08 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders


    Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
    Get Profile for Another Symbol: Symbol Lookup
    Annual ReportsSector Analysis